SPIA
MGRX icon

Steward Partners Investment Advisory’s Mangoceuticals MGRX Stock Holding History

Steward Partners Investment Advisory’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,094
Closed -$4.59K – 4418
2025
Q3 		$4.59K Hold
2,094
– – ﹤0.01% 3683
2025
Q2 		$3.18K Hold
2,094
– – ﹤0.01% 3613
2025
Q1 		$4.08K Hold
2,094
– – ﹤0.01% 3442
2024
Q4 		$5.07K Buy
2,094
+1
+0% +$3 ﹤0.01% 3360
2024
Q3 		$7.41K Buy
+2,093
New +$9.88K ﹤0.01% 3063

Other funds holding MGRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Steward Partners Investment Advisory's MGRX Position: Q4 2025 in Review

Steward Partners Investment Advisory sold out of Mangoceuticals (MGRX) in Q4 2025, closing a stake of 2,094 shares — an estimated $4.59K sold.

Steward Partners Investment Advisory first reported a position in MGRX in Q3 2024 and held it in 5 quarters. The position peaked at $7.41K in Q3 2024. 18 funds tracked by Wall St. Rank hold MGRX as of Q4 2025.

  • Steward Partners Investment Advisory reported no remaining Mangoceuticals position as of Q4 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 2,094 Mangoceuticals shares in Q4 2025, an estimated $4.59K.
  • Steward Partners Investment Advisory first reported a position in Mangoceuticals in Q3 2024 and held it in 5 quarters.
  • Steward Partners Investment Advisory's Mangoceuticals position peaked at $7.41K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q4 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2025, filed 12 Feb 2026.